479 related articles for article (PubMed ID: 17203207)
1. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
3. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis.
Napoli J; Prentice D; Niinami C; Bishop GA; Desmond P; McCaughan GW
Hepatology; 1997 Sep; 26(3):624-33. PubMed ID: 9303492
[TBL] [Abstract][Full Text] [Related]
4. Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.
Funakoshi F; Masaki T; Kita Y; Hitomi M; Kurokohchi K; Uchida N; Watanabe S; Yoshiji H; Kuriyama S
Int J Mol Med; 2004 Jun; 13(6):779-87. PubMed ID: 15138612
[TBL] [Abstract][Full Text] [Related]
5. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ
Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211
[TBL] [Abstract][Full Text] [Related]
6. Increased iron deposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine.
Guo L; Enzan H; Hayashi Y; Miyazaki E; Jin Y; Toi M; Kuroda N; Hiroi M
Exp Mol Pathol; 2006 Dec; 81(3):255-61. PubMed ID: 16979622
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
9. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
Choi HK; Pokharel YR; Lim SC; Han HK; Ryu CS; Kim SK; Kwak MK; Kang KW
Toxicol Appl Pharmacol; 2009 Nov; 240(3):377-84. PubMed ID: 19647758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
[TBL] [Abstract][Full Text] [Related]
13. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
14. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R
Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387
[TBL] [Abstract][Full Text] [Related]
15. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J
J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028
[TBL] [Abstract][Full Text] [Related]
16. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation.
Sferra R; Vetuschi A; Catitti V; Ammanniti S; Pompili S; Melideo D; Frieri G; Gaudio E; Latella G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1484-98. PubMed ID: 23111960
[TBL] [Abstract][Full Text] [Related]
17. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
Li Q; Zhou X; Yu J; Qian W; Xu KS
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
20. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
